vs
Idexx Laboratories（IDXX）とRANGE RESOURCES CORP（RRC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Idexx Laboratoriesの直近四半期売上が大きい（$1.1B vs $786.9M、RANGE RESOURCES CORPの約1.4倍）。RANGE RESOURCES CORPの純利益率が高く（22.8% vs 22.8%、差は0.0%）。RANGE RESOURCES CORPの前年同期比売上増加率が高い（18.0% vs 14.3%）。過去8四半期でRANGE RESOURCES CORPの売上複合成長率が高い（14.6% vs 6.4%）
IDEXXラボラトリーズは1983年設立の米国多国籍企業で、伴侶動物獣医療、家畜・家禽、水質検査、乳製品分野向けの製品・サービスの開発・製造・流通を手がけています。本社はメイン州ウェストブルックにあり、EMEA地域の拠点はオランダのホーフドルプに置かれています。
Range Resources Corporationは米国テキサス州フォートワースに本社を置く天然ガス探鉱・生産企業です。主力事業エリアのマーセラス頁岩層において同地域最大の土地保有者として事業を展開しています。
IDXX vs RRC — 直接比較
売上が大きい
IDXX
1.4倍大きい
$786.9M
売上成長率が高い
RRC
+3.7%の差
14.3%
純利益率が高い
RRC
純利益率が0.0%高い
22.8%
2年売上CAGRが高い
RRC
2年複合成長率
6.4%
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $1.1B | $786.9M |
| 純利益 | $248.2M | $179.1M |
| 粗利率 | 60.3% | 94.5% |
| 営業利益率 | 28.9% | — |
| 純利益率 | 22.8% | 22.8% |
| 売上前年比 | 14.3% | 18.0% |
| 純利益前年比 | 14.8% | 88.8% |
| EPS（希薄化後） | $3.09 | $0.75 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上IDXXRRC
| Q4 25 | $1.1B | $786.9M | ||
| Q3 25 | $1.1B | $655.3M | ||
| Q2 25 | $1.1B | $699.6M | ||
| Q1 25 | $998.4M | $846.3M | ||
| Q4 24 | $954.3M | $667.0M | ||
| Q3 24 | $975.5M | $567.9M | ||
| Q2 24 | $1.0B | $513.2M | ||
| Q1 24 | $964.1M | $598.8M |
純利益IDXXRRC
| Q4 25 | $248.2M | $179.1M | ||
| Q3 25 | $274.6M | $144.3M | ||
| Q2 25 | $294.0M | $237.6M | ||
| Q1 25 | $242.7M | $97.1M | ||
| Q4 24 | $216.1M | $94.8M | ||
| Q3 24 | $232.8M | $50.7M | ||
| Q2 24 | $203.3M | $28.7M | ||
| Q1 24 | $235.6M | $92.1M |
粗利率IDXXRRC
| Q4 25 | 60.3% | 94.5% | ||
| Q3 25 | 61.8% | 92.5% | ||
| Q2 25 | 62.6% | 95.0% | ||
| Q1 25 | 62.4% | 93.1% | ||
| Q4 24 | 59.8% | 93.7% | ||
| Q3 24 | 61.1% | 94.3% | ||
| Q2 24 | 61.7% | 93.4% | ||
| Q1 24 | 61.5% | 94.7% |
営業利益率IDXXRRC
| Q4 25 | 28.9% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 31.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 31.2% | — | ||
| Q2 24 | 26.3% | — | ||
| Q1 24 | 31.0% | — |
純利益率IDXXRRC
| Q4 25 | 22.8% | 22.8% | ||
| Q3 25 | 24.8% | 22.0% | ||
| Q2 25 | 26.5% | 34.0% | ||
| Q1 25 | 24.3% | 11.5% | ||
| Q4 24 | 22.7% | 14.2% | ||
| Q3 24 | 23.9% | 8.9% | ||
| Q2 24 | 20.3% | 5.6% | ||
| Q1 24 | 24.4% | 15.4% |
EPS（希薄化後）IDXXRRC
| Q4 25 | $3.09 | $0.75 | ||
| Q3 25 | $3.40 | $0.60 | ||
| Q2 25 | $3.63 | $0.99 | ||
| Q1 25 | $2.96 | $0.40 | ||
| Q4 24 | $2.62 | $0.38 | ||
| Q3 24 | $2.80 | $0.21 | ||
| Q2 24 | $2.44 | $0.12 | ||
| Q1 24 | $2.81 | $0.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $180.1M | $204.0K |
| 総負債低いほど良い | $450.0M | $1.2B |
| 株主資本純資産 | $1.6B | $4.3B |
| 総資産 | $3.4B | $7.4B |
| 負債/資本比率低いほどレバレッジが低い | 0.28× | 0.28× |
8四半期トレンド — 暦四半期で整列
現金・短期投資IDXXRRC
| Q4 25 | $180.1M | $204.0K | ||
| Q3 25 | $208.2M | $175.0K | ||
| Q2 25 | $164.6M | $134.0K | ||
| Q1 25 | $164.0M | $344.6M | ||
| Q4 24 | $288.3M | $304.5M | ||
| Q3 24 | $308.6M | $277.4M | ||
| Q2 24 | $401.6M | $251.1M | ||
| Q1 24 | $397.4M | $343.1M |
総負債IDXXRRC
| Q4 25 | $450.0M | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | $617.8M | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
株主資本IDXXRRC
| Q4 25 | $1.6B | $4.3B | ||
| Q3 25 | $1.6B | $4.2B | ||
| Q2 25 | $1.5B | $4.1B | ||
| Q1 25 | $1.4B | $3.9B | ||
| Q4 24 | $1.6B | $3.9B | ||
| Q3 24 | $1.6B | $3.9B | ||
| Q2 24 | $1.6B | $3.9B | ||
| Q1 24 | $1.6B | $3.8B |
総資産IDXXRRC
| Q4 25 | $3.4B | $7.4B | ||
| Q3 25 | $3.4B | $7.2B | ||
| Q2 25 | $3.3B | $7.1B | ||
| Q1 25 | $3.2B | $7.4B | ||
| Q4 24 | $3.3B | $7.3B | ||
| Q3 24 | $3.4B | $7.2B | ||
| Q2 24 | $3.4B | $7.3B | ||
| Q1 24 | $3.4B | $7.4B |
負債/資本比率IDXXRRC
| Q4 25 | 0.28× | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | 0.39× | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $355.8M | $257.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $326.3M | — |
| FCFマージンFCF / 売上 | 29.9% | — |
| 設備投資強度設備投資 / 売上 | 2.7% | — |
| キャッシュ転換率営業CF / 純利益 | 1.43× | 1.44× |
| 直近12ヶ月FCF直近4四半期 | $1.1B | — |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローIDXXRRC
| Q4 25 | $355.8M | $257.5M | ||
| Q3 25 | $402.3M | $247.5M | ||
| Q2 25 | $185.7M | $336.2M | ||
| Q1 25 | $238.0M | $330.1M | ||
| Q4 24 | $262.0M | $217.9M | ||
| Q3 24 | $220.1M | $245.9M | ||
| Q2 24 | $248.3M | $148.8M | ||
| Q1 24 | $198.6M | $331.9M |
フリーキャッシュフローIDXXRRC
| Q4 25 | $326.3M | — | ||
| Q3 25 | $371.2M | — | ||
| Q2 25 | $151.6M | — | ||
| Q1 25 | $207.9M | — | ||
| Q4 24 | $232.8M | — | ||
| Q3 24 | $192.0M | — | ||
| Q2 24 | $215.0M | — | ||
| Q1 24 | $168.3M | — |
FCFマージンIDXXRRC
| Q4 25 | 29.9% | — | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 20.8% | — | ||
| Q4 24 | 24.4% | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 21.4% | — | ||
| Q1 24 | 17.5% | — |
設備投資強度IDXXRRC
| Q4 25 | 2.7% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.1% | — |
キャッシュ転換率IDXXRRC
| Q4 25 | 1.43× | 1.44× | ||
| Q3 25 | 1.47× | 1.72× | ||
| Q2 25 | 0.63× | 1.42× | ||
| Q1 25 | 0.98× | 3.40× | ||
| Q4 24 | 1.21× | 2.30× | ||
| Q3 24 | 0.95× | 4.85× | ||
| Q2 24 | 1.22× | 5.18× | ||
| Q1 24 | 0.84× | 3.60× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
